Bioventus Inc. (BVS) Social Stream
BIOVENTUS INC (BVS) Price Targets From Analysts
Use the tables below to see what analysts covering BIOVENTUS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-03-08 | 1 | $23 | $23 | $23 | $2.11 | 990.05% |
2021-11-10 | 3 | $25 | $23 | $24 | $2.11 | 1037.44% |
2022-01-25 | 3 | $25 | $20 | $22.666 | $2.11 | 974.22% |
2022-05-11 | 3 | $30 | $18 | $23 | $2.11 | 990.05% |
2022-07-14 | 3 | $30 | $11 | $20.666 | $2.11 | 879.43% |
2022-08-12 | 3 | $30 | $12 | $18 | $2.11 | 753.08% |
2022-09-07 | 4 | $30 | $12 | $16.75 | $2.11 | 693.84% |
2022-10-11 | 4 | $30 | $11 | $16.5 | $2.11 | 681.99% |
2022-11-09 | 3 | $10 | $5 | $7 | $2.11 | 231.75% |
2022-11-30 | 4 | $10 | $2.5 | $5.875 | $2.11 | 178.44% |
The Trend in the Analyst Price Target
Over the past 29 weeks, BVS's average price target has gone down $17.12.
Over the past 37 weeks, BVS's average upside potential has been 161.03%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-15 | 3 | 30 | 18 | 23.0 | 13.45 | 71% |
2022-04-11 | 3 | 30 | 18 | 23.0 | 12.90 | 78.29% |
2022-08-12 | 3 | 30 | 12 | 18.0 | 9.08 | 98.24% |
2022-10-11 | 4 | 30 | 11 | 16.5 | 6.71 | 145.9% |
2022-11-09 | 4 | 13 | 5 | 8.5 | 2.58 | 229.46% |
BVS Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3.5 | 0 | 0 | 3 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
Over the past 35 weeks, BVS's average broker recommendation rating worsened by 2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BIOVENTUS INC's upside potential (average analyst target price relative to current price) is higher than 1602.34% of all US stocks.
- In the context of all US stocks, BIOVENTUS INC's number of analysts covering the stock is greater than 198.21% of them.
- To contextualize these metrics, consider that out of all US stocks, BIOVENTUS INC's variance in analysts' estimates is lower than -901.46% of them.
- In the context of Medical Equipment stocks, BIOVENTUS INC's average analyst price target is greater than 416.19% of them.
In the Medical Equipment industry, NPCE, TMCI, and CVRX are the three stocks most similar to BIOVENTUS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BVS? Use POWR Ratings for clearer insight into price direction.